Heterocyclic compounds useful as PDK1 inhibitors
US10030016B2 · kind B2 · utility
0Cited by
3References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 11, 2015 |
| Grant date | Jul 24, 2018 |
| Priority date | — |
| Expiry date | Dec 11, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds useful as inhibitors of PDK1. The present invention also provides compositions thereof, and methods of treating PDK1-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.